EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Controlled Trials

Kiarash Tavakoli, Negin Sadat Hosseini Mohammadi, Pegah Bahiraie, Sahar Saeidi, Farhad Shaker, Arman Soltani Moghadam, Sara Montazeri Namin, Habib Rahban, Shubhadarshini Pawar, Masih Tajdini, Hamidreza Soleimani, Yaser Jenab und 6 weitere

Clinical Cardiology · 2025

DOI: 10.1002/clc.70134 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Kiarash Tavakoli und 17 weiteren Autor:innen. Beteiligte Einrichtung: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Balloon Valvuloplasty, Heart Valve Prosthesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comparisons of outcomes after transcatheter aortic valve replacement with balloon‐expandable (BEV) versus self‐expanding (SEV) valves are limited. Hypothesis This study aimed to compare clinical and hemodynamic outcomes of BEV and SEV at short‐term (30 days), midterm (1 year), and long‐term (> 1 year) endpoints.

Methods

PubMed, Embase, Scopus, and Cochrane Library databases were searched until July 2024 for randomized controlled trials. Random‐effect model (DerSimonian–Laird method) was used to pool the risk ratios (RR), mean differences, and 95% confidence intervals (CI).

Results

A total of 10 studies comprising 4325 patients (2295 BEV, 2030 SEV) were included. In short‐term, cardiovascular (RR: 0.56, 95% CI: 0.36–0.87) and all‐cause mortality (RR: 0.54, 95% CI: 0.35–0.81) were lower in the BEV group. Risk of moderate to severe paravalvular leak (PVL) was lower among BEV patients in short‐term (RR: 0.28, 95% CI: 0.17–0.49) and long‐term (RR: 0.28, 95% CI: 0.1–0.79). A limited number of studies showed a greater risk of clinical valve thrombosis on BEV in midterm and long‐term. The need for permanent pacemaker implantation was lower in BEV at both short‐term (RR: 0.56, 95% CI: 0.37–0.87), and midterm (RR: 0.78, 95% CI: 0.64–0.94). The SEV group had a larger effective orifice area with lower mean transvalvular pressure gradient at all endpoints.

Conclusions

BEV is associated with reduced risk of clinical outcomes in short‐term; however, most differences diminish in longer evaluations, except for moderate to severe PVL, which remains elevated for SEV. SEVs had better hemodynamic results and lower risk of clinical valve thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisBalloon ValvuloplastyHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementHumansHemodynamicsProsthesis DesignRandomized Controlled Trials as TopicTime FactorsTreatment Outcome

Stichwörter der Autor:innen

TAVRaortic stenosisballoon‐expandable valvesmeta‐analysisself‐expanding valvestranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cardiovascular Research Foundation of Southern California, Beverly Hills, CA, USA.
  • Department of Cardiovascular Disease, Creighton University School of Medicine, St. Joseph Hospital and Medical Center, Phoenix, AZ, USA.
  • Cedars Sinai Medical Center, California, Los Angeles, USA.
  • Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Tavakoli, K., Mohammadi, N. S. H., Bahiraie, P., Saeidi, S., Shaker, F., Moghadam, A. S., Namin, S. M., Rahban, H., Pawar, S., Tajdini, M., Soleimani, H., Jenab, Y., Ahmad, Y., Iskander, F. H., Alkhouli, M., Makkar, R., Gupta, A., & Hosseini, K. (2025). Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Controlled Trials. Clinical Cardiology. https://doi.org/10.1002/clc.70134

Vancouver

Tavakoli K, Mohammadi NSH, Bahiraie P, Saeidi S, Shaker F, Moghadam AS, et al. Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Controlled Trials. Clinical Cardiology. 2025. doi:10.1002/clc.70134

BibTeX
@article{Tavakoli2025,
  author = {Tavakoli, Kiarash and Mohammadi, Negin Sadat Hosseini and Bahiraie, Pegah and Saeidi, Sahar and Shaker, Farhad and Moghadam, Arman Soltani and Namin, Sara Montazeri and Rahban, Habib and Pawar, Shubhadarshini and Tajdini, Masih and Soleimani, Hamidreza and Jenab, Yaser and Ahmad, Yousif and Iskander, Fady Hany and Alkhouli, Mohamad and Makkar, Raj and Gupta, Aakriti and Hosseini, Kaveh},
  title = {Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Controlled Trials},
  journal = {Clinical Cardiology},
  year = {2025},
  doi = {10.1002/clc.70134}
}
Kostenlos starten →